Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-16 Sale |
2022-02-18 6:18 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
3,661 | $10.95 | $40,088 | 121,075 (Direct) |
View |
| 2022-02-16 Sale |
2022-02-18 6:18 pm |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
2,363 | $10.95 | $25,875 | 165,318 (Direct) |
View |
| 2022-02-16 Sale |
2022-02-18 6:16 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
12,480 | $10.95 | $136,656 | 589,430 (Indirect Direct) |
View |
| 2022-02-16 Sale |
2022-02-18 6:15 pm |
NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer |
4,852 | $10.95 | $53,129 | 227,802 (Direct) |
View |
| 2022-02-16 Sale |
2022-02-18 6:14 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
7,579 | $10.95 | $82,990 | 301,603 (Direct) |
View |
| 2021-11-16 Sale |
2021-11-18 6:06 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
24,149 | $13.1 | $316,391 | 256,682 (Direct) |
View |
| 2021-11-16 Sale |
2021-11-17 6:11 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
20,869 | $13.16 | $274,636 | 232,084 (Direct) |
View |
| 2021-11-16 Sale |
2021-11-17 6:09 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
6,564 | $13.16 | $86,382 | 86,436 (Direct) |
View |
| 2021-11-16 Sale |
2021-11-17 6:08 pm |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
6,741 | $13.16 | $88,712 | 145,981 (Direct) |
View |
| 2021-11-16 Sale |
2021-11-17 6:07 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
42,773 | $13.16 | $562,893 | 475,860 (Indirect Direct) |
View |
| 2021-11-16 Sale |
2021-11-17 6:06 pm |
NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer |
6,061 | $13.16 | $79,763 | 194,854 (Direct) |
View |
| 2021-09-22 Sale |
2021-09-24 6:14 pm |
NEKTAR THERAPEUTICS | NKTR | Curet Myriam Director |
3,665 | $17.78 | $65,164 | 46,175 (Direct) |
View |
| 2021-09-22 Sale |
2021-09-24 6:13 pm |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
4,600 | $17.94 | $82,524 | 306,573 (Indirect Direct) |
View |
| 2021-09-22 Sale |
2021-09-24 6:12 pm |
NEKTAR THERAPEUTICS | NKTR | Ajer Jeffrey Robert Director |
3,665 | $17.78 | $65,164 | 52,910 (Direct) |
View |
| 2021-09-08 Sale |
2021-09-10 6:03 pm |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
18,279 | $16.01 | $292,670 | 290,852 (Indirect Direct) |
View |
| 2021-08-16 Sale |
2021-08-18 7:04 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
7,662 | $13.83 | $105,965 | 212,803 (Direct) |
View |
| 2021-08-16 Sale |
2021-08-18 7:02 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
1,910 | $13.83 | $26,415 | 72,900 (Direct) |
View |
| 2021-08-16 Sale |
2021-08-18 7:01 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
11,515 | $13.83 | $159,252 | 424,533 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-12-16 Option Award |
2021-12-20 8:28 pm |
N/A 2029-12-15 |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
146,950 | $0 | 379,034 (Direct) |
View |
| 2021-12-16 Option Award |
2021-12-20 8:27 pm |
N/A 2029-12-15 |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
104,950 | $0 | 191,886 (Direct) |
View |
| 2021-12-16 Option Award |
2021-12-20 8:26 pm |
N/A 2029-12-15 |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
58,800 | $0 | 205,281 (Direct) |
View |
| 2021-12-16 Option Award |
2021-12-20 8:25 pm |
N/A 2029-12-15 |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
349,800 | $0 | 825,660 (Direct) |
View |
| 2021-12-16 Option Award |
2021-12-20 8:24 pm |
N/A 2029-12-15 |
NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer |
104,950 | $0 | 299,804 (Direct) |
View |
| 2021-12-16 Option Award |
2021-12-20 8:23 pm |
N/A 2029-12-15 |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
146,950 | $0 | 403,182 (Direct) |
View |
| 2021-11-15 Option Award |
2021-11-17 6:11 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
40,150 | $0 | 232,084 (Direct) |
View |
| 2021-11-15 Option Award |
2021-11-17 6:09 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
20,100 | $0 | 86,436 (Direct) |
View |
| 2021-11-15 Option Award |
2021-11-17 6:08 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
14,900 | $0 | 145,981 (Direct) |
View |
| 2021-11-15 Option Award |
2021-11-17 6:07 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
94,100 | $0 | 475,860 (Direct) |
View |
| 2021-11-15 Option Award |
2021-11-17 6:04 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
40,150 | $0 | 280,831 (Direct) |
View |
| 2021-11-11 Option Award |
2021-11-15 5:08 pm |
N/A 2029-11-10 |
NEKTAR THERAPEUTICS | NKTR | Brainard Diana Director |
55,080 | $0 | 55,080 (Direct) |
View |
| 2021-11-09 Exercise |
2021-11-09 5:05 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | GREER R SCOTT Director |
12,500 | $12.8 | 293,374 (Direct) |
View |
| 2021-11-09 Exercise |
2021-11-09 5:05 pm |
2016-09-15 2023-09-14 |
NEKTAR THERAPEUTICS | NKTR | GREER R SCOTT Director |
12,500 | $0 | 293,374 (Direct) |
View |
| 2021-10-12 Option Award |
2021-10-14 9:10 pm |
N/A 2027-12-11 |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
71,550 | $0 | 71,550 (Direct) |
View |
| 2021-10-12 Option Award |
2021-10-14 9:09 pm |
N/A 2027-12-11 |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
35,800 | $0 | 35,800 (Direct) |
View |
| 2021-10-12 Option Award |
2021-10-14 9:07 pm |
N/A 2027-12-11 |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
26,600 | $0 | 26,600 (Direct) |
View |
| 2021-10-12 Option Award |
2021-10-14 9:06 pm |
N/A 2027-12-11 |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
167,650 | $0 | 167,650 (Direct) |
View |
| 2021-10-12 Option Award |
2021-10-14 9:05 pm |
N/A 2027-12-11 |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
71,550 | $0 | 71,550 (Direct) |
View |
| 2021-09-22 Option Award |
2021-09-24 6:16 pm |
N/A 2029-09-21 |
NEKTAR THERAPEUTICS | NKTR | WHITFIELD ROY A Director |
30,600 | $0 | 327,950 (Direct) |
View |
| 2021-09-22 Option Award |
2021-09-24 6:16 pm |
N/A 2029-09-21 |
NEKTAR THERAPEUTICS | NKTR | GREER R SCOTT Director |
30,600 | $0 | 301,274 (Direct) |
View |
| 2021-09-22 Option Award |
2021-09-24 6:15 pm |
N/A 2029-09-21 |
NEKTAR THERAPEUTICS | NKTR | EASTHAM KARIN Director |
30,600 | $0 | 54,700 (Direct) |
View |
| 2021-09-22 Option Award |
2021-09-24 6:14 pm |
N/A 2029-09-21 |
NEKTAR THERAPEUTICS | NKTR | Curet Myriam Director |
30,600 | $0 | 46,175 (Direct) |
View |
| 2021-09-22 Option Award |
2021-09-24 6:13 pm |
N/A 2029-09-21 |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
30,600 | $0 | 306,573 (Direct) |
View |
| 2021-09-22 Option Award |
2021-09-24 6:12 pm |
N/A 2029-09-21 |
NEKTAR THERAPEUTICS | NKTR | Ajer Jeffrey Robert Director |
30,600 | $0 | 52,910 (Direct) |
View |
| 2021-09-16 Exercise |
2021-09-17 6:44 pm |
2014-09-30 2021-09-18 |
NEKTAR THERAPEUTICS | NKTR | WHITFIELD ROY A Director |
40,000 | $0 | 297,350 (Direct) |
View |
| 2021-09-16 Exercise |
2021-09-17 6:44 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | WHITFIELD ROY A Director |
40,000 | $13.8 | 297,350 (Direct) |
View |
| 2021-09-08 Exercise |
2021-09-10 6:03 pm |
2014-09-30 2021-09-18 |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
18,279 | $0 | 290,852 (Direct) |
View |
| 2021-09-08 Exercise |
2021-09-10 6:03 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
18,279 | $13.8 | 290,852 (Direct) |
View |
| 2021-08-31 Exercise |
2021-08-31 6:26 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | GREER R SCOTT Director |
45,000 | $12.7 | 270,674 (Direct) |
View |
| 2021-08-31 Exercise |
2021-08-31 6:26 pm |
2015-09-30 2022-09-22 |
NEKTAR THERAPEUTICS | NKTR | GREER R SCOTT Director |
45,000 | $0 | 270,674 (Direct) |
View |
| 2021-08-24 Gift |
2021-08-26 7:01 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
8,400 | $0 | 276,373 (Direct) |
View |